These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 2454214)

  • 1. Morphologic differences in the pattern of liver infiltration between systemic AL and AA amyloidosis.
    Looi LM; Sumithran E
    Hum Pathol; 1988 Jun; 19(6):732-5. PubMed ID: 2454214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic amyloidosis: morphologic differences between systemic AL and AA types.
    Buck FS; Koss MN
    Hum Pathol; 1991 Sep; 22(9):904-7. PubMed ID: 1916751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic amyloidosis. A histopathologic analysis of primary (AL) and secondary (AA) forms.
    Chopra S; Rubinow A; Koff RS; Cohen AS
    Am J Pathol; 1984 May; 115(2):186-93. PubMed ID: 6202147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification of amyloidosis: immunohistochemistry versus the potassium permanganate method in differentiating AA from AL amyloidosis.
    Janssen S; Elema JD; van Rijswijk MH; Limburg PC; Meijer S; Mandema E
    Appl Pathol; 1985; 3(1-2):29-38. PubMed ID: 3915945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic amyloidosis in Japan: histological and morphometric analysis based on amyloid proteins.
    Iwata T; Hoshii Y; Kawano H; Gondo T; Takahashi M; Ishihara T; Yokota T; Ueda J; Uchino F
    Hum Pathol; 1995 Oct; 26(10):1148-53. PubMed ID: 7557950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histochemical and immunohistochemical differential diagnosis of amyloidosis--a brief illustrated essay and personal experience with Romhányi's method.
    Bély M; Apáthy A
    Amyloid; 2000 Sep; 7(3):212-7. PubMed ID: 11019862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potassium permanganate method. A reliable method for differentiating amyloid AA from other forms of amyloid in routine laboratory practice.
    van Rijswijk MH; van Heusden CW
    Am J Pathol; 1979 Oct; 97(1):43-58. PubMed ID: 495695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic amyloidosis: morphologic spectrum of histopathological changes in AA and nonAA amyloidosis.
    Sarsik B; Sen S; Kirdok FS; Akarca US; Toz H; Yilmaz F
    Pathol Res Pract; 2012 Dec; 208(12):713-8. PubMed ID: 23154038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration and classification of amyloidosis in needle biopsies of the kidneys, with special reference to amyloidosis of the AA-type.
    Löfberg H; Thysell H; Westman K; Larsen S; Brun C; Gruic V; Grubb A
    Acta Pathol Microbiol Immunol Scand A; 1987 Nov; 95(6):357-63. PubMed ID: 3120491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical classification of 140 autopsy cases with systemic amyloidosis.
    Hoshii Y; Takahashi M; Ishihara T; Uchino F
    Pathol Int; 1994 May; 44(5):352-8. PubMed ID: 8044304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An investigation of the protein components of amyloid using immunoperoxidase and permanganate methods on tissue sections.
    Looi LM
    Pathology; 1986 Jan; 18(1):137-40. PubMed ID: 2425332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potassium permanganate resistant amyloid in fine-needle aspirate of the liver.
    Srinivasan R; Nijhawan R; Gautam U; Bambery P
    Diagn Cytopathol; 1994; 10(4):383-4. PubMed ID: 7924815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Usefulness of potassium permanganate staining in the classification of systemic amyloidoses].
    Pigrau C; Martínez-Vázquez JM; Ocaña I; Capdevila JA; Ribera E; Muñiz R; Vidal MT
    Med Clin (Barc); 1985 Mar; 84(8):302-4. PubMed ID: 2580195
    [No Abstract]   [Full Text] [Related]  

  • 14. Splenic amyloidosis: correlations between chemical types of amyloid protein and morphological features.
    Ohyama T; Shimokama T; Yoshikawa Y; Watanabe T
    Mod Pathol; 1990 Jul; 3(4):419-22. PubMed ID: 2217149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of evidence for protein AA reactivity in amyloid deposits of lattice corneal dystrophy and amyloid corneal degeneration.
    Gorevic PD; Rodrigues MM; Krachmer JH; Green C; Fujihara S; Glenner GG
    Am J Ophthalmol; 1984 Aug; 98(2):216-24. PubMed ID: 6383050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head and neck amyloidosis: clinicopathological features and immunohistochemical analysis of 14 cases.
    Gouvêa AF; Ribeiro AC; León JE; Carlos R; de Almeida OP; Lopes MA
    J Oral Pathol Med; 2012 Feb; 41(2):178-85. PubMed ID: 21883489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishing the fluorescent amyloid ligand h-FTAA for studying human tissues with systemic and localized amyloid.
    Sjölander D; Röcken C; Westermark P; Westermark GT; Nilsson KP; Hammarström P
    Amyloid; 2016 Jun; 23(2):98-108. PubMed ID: 26987044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of amyloid fibril proteins in tissue sections. Two simple and reliable histological methods applied to fifty-one cases of systemic amyloidosis.
    Fujihara S
    Acta Pathol Jpn; 1982 Sep; 32(5):771-82. PubMed ID: 6182740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Amyloidosis and hepatic amyloidosis].
    Murakami T; Yi S
    Nihon Rinsho; 1993 Feb; 51(2):453-7. PubMed ID: 8464159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Classification of cardiac amyloidosis: an immunohistochemical analysis].
    Li L; Duan XJ; Sun Y; Lu Y; Xu HY; Wang QZ; Wang HY
    Zhonghua Bing Li Xue Za Zhi; 2018 Feb; 47(2):105-109. PubMed ID: 29429161
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.